Zhao et al., 2006) and to improve LV function in dogs with dilated cardiomyopathy (Nikolaidis et al., 2005a), in which GLP-1 also attenuated reperfusion-related mechanical ventricular dysfunction not associated with irreversible myocardial damage (myocardial stunning) (Nikolaidis et al., 2005b)
The information is provided by Ulf-Daniel Ehlers and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose
The weight loss is thought to be caused by slowing digestion by increasing the time it takes for food to leave the body
What this new option may mean for GLP-1 utilization While the new oral version of Wegovy is generating buzz in the marketplace, it is not expected to have a major impact on either cost or utilization in the weight loss medication category
The dosage per kg will appear just below